Author:
Wang Peipei,Zhang Cuizhen,Lv Qinyu,Bao Chenxi,Sun Hong,Ma Guo,Fang Yiru,Yi Zhenghui,Cai Weimin
Funder
National Key R & D Program of China
the National Basic Research Program of China
the National Natural Science Foundation of China
Shanghai Science and Technology Commission Foundation
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology,General Medicine
Reference44 articles.
1. Whiteford HA, Degenhardt L, Rehm J, Baxter AJ, Ferrari AJ, Erskine HE, Charlson FJ, Norman RE, Flaxman AD, Johns N, Burstein R, Murray CJL, Vos T (2013) Global burden of disease attributable to mental and substance use disorders: findings from the global burden of disease study 2010. Lancet 382(9904):1575–1586.
https://doi.org/10.1016/S0140-6736(13)61611-6
2. Kenneth SK, Margaret G, Charles OG, Nancy LP (2006) A Swedish national twin study of lifetime major depression. Am J Psychiatry 163:109–114
3. Ozomaro U, Wahlestedt C, Nemeroff CB (2013) Personalized medicine in psychiatry: problems and promises. BMC Med 11:132.
https://doi.org/10.1186/1741-7015-11-132
4. Gibson T, Jing Y, Smith CG, Kim E, Bagalman J, Burton W, Tran Q, Pikalov A, Goetzel R (2010) Cost burden of treatment resistance in patients with depression. Am J Manag Care 16(5):370–377
5. Fava M (2003) Diagnosis and definition of treatment-resistant depression. Biol Psychiat 53(8):649–659.
https://doi.org/10.1016/S0006-3223(03)00231-2
Cited by
47 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献